Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP

See results from clinical trials with Trulicity when assessed for A1C reduction, weight change and CV risk reduction.

PDF) Shared decision making in type 2 diabetes with a support decision tool that takes into account clinical factors, the intensity of treatment and patient preferences: Design of a cluster randomised (OPTIMAL)

Frontiers Changes in body weight and cardiovascular risk factors in a Chinese population with type 2 diabetes mellitus: a longitudinal study

PDF) Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study

Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP

A1C and Weight Results RYBELSUS® (semaglutide) tablets 7 mg or 14 mg

IJERPH, Free Full-Text

A1C and Weight Results RYBELSUS® (semaglutide) tablets 7 mg or 14 mg

Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3 CKD – AJKD Blog

American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update - ScienceDirect

Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial. - Abstract - Europe PMC

Diabetes Canada Clinical Practice Guidelines

Medication Updates Archives - Diabetes Education Services

Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP